92089-09-3Relevant articles and documents
EX VIVO METHODS FOR PREDICTING AND CONFIRMING IN VIVO METABOLISM OF PHARMACEUTICALLY ACTIVE COMPOUNDS
-
Page/Page column 38; 39; 40, (2015/06/25)
Methods and compositions for the catalytic oxidation of pharmaceutically active compounds, and more particularly to ex vivo methods for predicting in vivo metabolism of pharmaceutically active compounds, including predicting in vivo interaction between two or more pharmaceutically active compounds.
Cyclic hydroxamic acids of the phenanthridine type - Synthesis and investigation of lipoxigenase inhibition
Goerlitzer,Dobberkau,Ewert,Heinrici,Bartke,Buss,Kupfer,Nuhn
, p. 575 - 578 (2007/10/03)
The synthesis of the benzo[f]furo[3,4-c] [2,7]naphthyridines 15 and 17, the thieno[2,3-c] [2,7]naphthyridines 21 as well as the pyrimido[5,4-c]quinoline 25 is described. These compounds and the structurally related diaza- and triaza-phenanthrenes 3-8 were
FORMATION OF FURO- AND DIFURO-1,4-DIHYDROPYRIDINES IN THE BROMINATION OF 2,6-DIMETHYL-3,5-DIMETHOXYCARBONYL-4-(o-NITROPHENYL)-1,4-DIHYDROPYRIDINE
Skrastin'sh, I. P.,Kastron, V. V.,Dubur, G. Ya.,Mazheika, I. B.,Kadysh, V. P.
, p. 981 - 985 (2007/10/02)
Furo- and difuro-1,4-dihydropyridines were obtained by bromination of 2,6-dimethyl-3,5-dimethoxycarbonyl-4-(o-nitrophenyl)-1,4-dihydropyridine with mild brominating agents (pyridinium bromide perbromide, N-bromosuccinimide, and dioxane dibromide).